Evidence map›Paper›PMID 25921732›Full record

ArticleNeuroscience2015

The effect of mild traumatic brain injury on peripheral nervous system pathology in wild-type mice and the G93A mutant mouse model of motor neuron disease.

T M Evans, C A Jaramillo, K Sataranatarajan, L Watts, M Sabia, W Qi, H Van Remmen

Abstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 22 citations in OpenAlex.

  1. iPLAScience advances · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Motor Effects of Minimal Traumatic Brain Injury in Mice.Journal of molecular neuroscience : MN · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

T M EvansDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: EvansTM@uthscsa.edu.
C A JaramilloPolytrauma Rehabilitation Center, San Antonio, TX, USA; South Texas Veterans Health Care System, San Antonio, TX, USA; Department of Rehabilitation Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: jaramilloc3@uthscsa.edu.
K SataranatarajanOklahoma Medical Research Foundation, Oklahoma City, OK, USA; Oklahoma City VA Medical Center, Oklahoma City, OK, USA. Electronic address: Kavithalakshmi-Sataranatarajan@omrf.org.
L WattsDepartment of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: wattsl@uthscsa.edu.
M SabiaSouth Texas Veterans Health Care System, San Antonio, TX, USA. Electronic address: sabia@uthscsa.edu.
W QiSouth Texas Veterans Health Care System, San Antonio, TX, USA. Electronic address: Qi@uthscsa.edu.
H Van RemmenDepartment of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Oklahoma City VA Medical Center, Oklahoma City, OK, USA. Electronic address: holly-vanremmen@omrf.org.
The University of Texas Health Science Center at San Antonio · USOklahoma Medical Research Foundation · USSouth Texas Veterans Health Care System · US

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthKL2TR001118 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, DOUGHERTY, DONALD M · 2013 to 2017
$3.4M
The mechanism linking traumatic brain injury to amyotrophic lateral sclerosisF31NS080508 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI EVANS, TERESA · 2012 to 2013
$53k
Targeted investigation of tissue specific oxidative stress in the etiology of ALSI01BX000517 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI VAN REMMEN, HOLLY · 2011 to 2013
–
BLRD VA I01 BX000517NCATS NIH HHS KL2 TR001118NCATS NIH HHS UL1 TR001120NINDS NIH HHS 1F31NS080508-01NINDS NIH HHS F31 NS080508
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is associated with a risk of neurodegenerative disease. Some suggest a link between TBI and motor neuron disease (MND), including amyotrophic lateral sclerosis (ALS). To investigate the potential mechanisms linking TBI to MND, we measured motor function and neuropathology following mild-TBI in wild-type and a transgenic model of ALS, G93A mutant mice. Mild-TBI did not alter the lifespan of G93A mice or age of onset; however, rotarod performance was impaired in G93A verses wild-type mice. Grip strength was reduced only in G93A mice after mild-TBI. Increased electromyography (EMG) abnormalities and markers of denervation (AchR, Runx1) indicate that mild-TBI may result in peripheral effects that are exaggerated in G93A mice. Markers of inflammation (cell edema, astrogliosis and microgliosis) were detected at 24 and 72h in the brain and spinal cord in wild-type and G93A mice. Levels of F2-isoprostanes, a marker of oxidative stress, were increased in the spinal cord 24h post mild-TBI in wild-type mice but were not affected by TBI in G93A mice. In summary, our data demonstrate that mild-TBI induces inflammation and oxidative stress and negatively impacts muscle denervation and motor performance, suggesting mild-TBI can potentiate motor neuron pathology and influence the development of MND in mice.

Indexed as

Age FactorsAnimalsBrain InjuriesCell Cycle ProteinsCore Binding Factor Alpha 2 SubunitDisease Models, AnimalGADD45 ProteinsGene Expression RegulationGlial Fibrillary Acidic ProteinMiceMice, Inbred C57BLMice, TransgenicMotor Neuron DiseaseMuscle StrengthMutationMyoD ProteinCell Cycle ProteinsCore Binding Factor Alpha 2 SubunitGadd45a protein, mouseGADD45 ProteinsGlial Fibrillary Acidic ProteinMyoD ProteinNuclear ProteinsReceptors, CholinergicSOD1 G93A proteinSuperoxide Dismutaseamyotrophic lateral sclerosismouse modeloxidative stressspinal cordTBI

Identifiers

PMID25921732
PMCPMC4470701
OpenAlexW1972768857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.